Stockscreener 앱 받기
2.42
0.83%
0.02
시간 외 거래:
2.42
Maravai Lifesciences Holdings Inc 주식(MRVI)의 최신 뉴스
Bullish Divergence Spotted in Maravai LifeSciences Holdings Inc. MomentumMarket Activity Summary & Verified Momentum Stock Watchlist - beatles.ru
Is Maravai LifeSciences Holdings Inc. meeting your algorithmic filter criteria2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
Risk adjusted return profile for Maravai LifeSciences Holdings Inc. analyzedGap Down & Weekly Watchlist for Hot Stocks - Newser
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2025 Earnings Call Transcript - MSN
Will Maravai LifeSciences Holdings Inc. see short term momentumMarket Movers & AI Enhanced Execution Alerts - Newser
Short interest data insights for Maravai LifeSciences Holdings Inc.July 2025 Analyst Calls & Scalable Portfolio Growth Ideas - Newser
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences Holdings Inc. stock trend outlook and recovery pathQuarterly Trade Summary & High Yield Stock Recommendations - Newser
Should you hold or exit Maravai LifeSciences Holdings Inc. nowAnalyst Downgrade & Smart Allocation Stock Tips - Newser
Earnings visualization tools for Maravai LifeSciences Holdings Inc.Weekly Profit Summary & Weekly High Potential Stock Alerts - Newser
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition - MSN
How to forecast Maravai LifeSciences Holdings Inc. trends using time seriesMarket Movers & AI Driven Stock Reports - Newser
Is Maravai LifeSciences Holdings Inc. trending in predictive chart models2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Maravai LifeSciences Holdings Inc. stock daily chart insights2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
Has Maravai LifeSciences Holdings Inc. found a price floorJuly 2025 Review & Accurate Intraday Trade Tips - Newser
How to use a screener to detect Maravai LifeSciences Holdings Inc. breakouts - Newser
Can you recover from losses in Maravai LifeSciences Holdings Inc.Quarterly Growth Report & Verified Short-Term Trading Plans - Newser
What candlestick patterns are forming on Maravai LifeSciences Holdings Inc.Weekly Market Report & Reliable Price Breakout Signals - Newser
Sentiment analysis tools applied to Maravai LifeSciences Holdings Inc.Recession Risk & Low Drawdown Investment Ideas - Newser
Maravai LifeSciences Announces Restructuring Amid Revenue Decline - TipRanks
Live market analysis of Maravai LifeSciences Holdings Inc.Profit Target & Verified Stock Trade Ideas - Newser
Is Maravai LifeSciences Holdings Inc. Forming a Bottom PatternTrade Entry Summary & Community Trade Idea Sharing Platform - thegnnews.com
Published on: 2025-08-15 03:37:48 - thegnnews.com
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price - simplywall.st
Maravai LifeSciences Holdings Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
3 Promising Penny Stocks With At Least $200M Market Cap - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Price Target Cut to $5.00 by Analysts at Royal Bank Of Canada - Defense World
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Acquired by XTX Topco Ltd - Defense World
Maravai Lifesciences Holdings (MRVI) Maintains Buy Rating at RBC Capital with $5.00 Target Price - AInvest
Guggenheim Maintains Hold Rating on Maravai Lifesciences Holdings, Analyst Consensus Sees 85.92% Upside - AInvest
Maravai LifeSciences Announces Cost-Cutting Plan - 富途牛牛
RBC Capital Maintains MRVI Rating, Lowers Price Target | MRVI St - GuruFocus
Maravai LifeScience stock maintains Buy rating at Stifel despite guidance withdrawal - Investing.com Nigeria
Maravai LifeScience stock maintains Buy rating at Stifel despite guidance withdrawal By Investing.com - Investing.com South Africa
Maravai: RBC Capital Keeps Outperform, Cuts PT to $5 from $7. - AInvest
Maravai Lifesciences Announces Major Organizational Restructuring - MSN
Maravai (MRVI) Surges 27% on Restructuring Hopes and Earnings Drama: Is This a Short-Term Bounce or a Structural Turnaround? - AInvest
Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI) - The Globe and Mail
Deutsche Bank Adjusts Maravai Lifesciences Price Target to $4.50 From $5, Maintains Buy Rating - MarketScreener
Maravai signals $50M annualized cost reduction plan as leadership targets positive EBITDA in 2026 - MSN
Maravai LifeSciences Q2 2025 Earnings Call Transcript - MarketBeat
Maravai LifeSciences Holdings Inc (MRVI) Q2 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Lags Revenue Estimates - MSN
Maravai LifeSciences Holdings Inc (MRVI) Q2 2025 Earnings Call Highlights: Navigating ... By GuruFocus - Investing.com Canada
Maravai Lifesciences Holdings Maintains Buy Rating with $4.25 Price Target - AInvest
Maravai LifeSciences' Q2 2025: Key Contradictions in Revenue Dynamics and Strategic Outlook - AInvest
Maravai LifeSciences: Navigating Restructuring and Strategic Levers for Long-Term Value Creation - AInvest
Maravai LifeSciences Reports $50M Annualized Cost Reduction Plan, Targets Positive EBITDA by 2026 - AInvest
Maravai LifeSciences Holdings, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:MRVI) - Seeking Alpha
Transcript : Maravai LifeSciences Holdings, Inc., Q2 2025 Earnings Call, Aug 11, 2025 - MarketScreener
Earnings call transcript: Maravai Lifesciences Q2 2025 sees stock dip despite revenue growth - Investing.com Nigeria
Visual analytics tools that track Maravai LifeSciences Holdings Inc. performanceFree Swing Setup With Technical Confirmation - Newser
0.95%
0.90%
자본화:
|
볼륨(24시간):